Back to the peptide atlas
Skin & cosmeticsPeptideNot FDA/EMA approved

AHK-Cu

Copper-binding tripeptide

Also known as: Copper tripeptide AHK · Alanine-Histidine-Lysine copper

No account · this device only

The essentials at a glance

Classification
Peptide · Skin & cosmetics
Mechanism
Copper-binding tripeptide studied in skin and hair models
Evidence
Preclinical
Status
Not FDA/EMA approved

Discussed mainly in cosmetic skin and hair models; medicinal benefit and safety are unconfirmed.

Distinction: AHK-Cu is discussed mainly in cosmetic hair and skin models, while GHK-Cu is studied more broadly around skin matrix and collagen signalling.

Evidence strengthPreclinical

Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.

Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

Research questions

Mechanism: AHK-Cu

01

Copper-binding tripeptide

This studies how a short peptide binds copper ions and may support cell signalling in skin tissue, similar to a transport container for an important trace element. Collagen markers and cell activity in skin models are measured.

02

Skin matrix signalling

This examines how signals affect collagen and other structural proteins that give skin its firmness and elasticity, similar to studying the scaffolding beneath a building's surface. Researchers typically measure collagen production and skin structure in laboratory skin models.

03

Cell migration peptide

This studies how a peptide influences the migration of cells toward an injury site, similar to workers rushing to a construction site. Speed and extent of cell migration are measured in lab models.

Simple example

Cosmetic ingredient

Think of it like an ingredient in a skin cream meant to act on the skin surface, similar to other common care ingredients.

Cosmetic use does not presuppose medical efficacy and is tested differently from medicines.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Skin and hair anecdotes

Users exchange personal impressions of skin appearance, wrinkle depth, or hair growth after using cosmetically marketed peptides, usually based on their own photos rather than measurement devices. Such subjective impressions and marketing claims are not proof of a confirmed effect.

Vendor marketing claims

Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Evidence boundary

Confirmed medicinal benefit has not yet been established.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.